KwikEngage

Remote Study Participation

Published by: Obvio Health USA

Description

The ObvioGo™ app is a purpose-built mobile application designed to make clinical trial participation as easy and seamless as possible. As a pivotal piece of ObvioHealth’s configurable decentralized clinical trial (DCT) platform, this app enables participants to engage in clinical studies outside the traditional trial setting—from the comforts of home and as they go about their daily lives. The app’s features allow participants to provide consent, complete study tasks, report changes in health or medication, and communicate with the study team, all from the convenience of their personal iOS.
Hide Show More...

KwikEngage FAQ

  • Is KwikEngage free?

    Yes, KwikEngage is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is KwikEngage legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does KwikEngage cost?

    KwikEngage is free.

  • What is KwikEngage revenue?

    To get estimated revenue of KwikEngage app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Pakistan yet.
Ratings History

KwikEngage Reviews

App doesn't have any reviews yet

KwikEngage Competitors

ObvioGo Installs

Last 30 days

ObvioGo Revenue

Last 30 days

KwikEngage Revenue and Downloads

Gain valuable insights into ObvioGo performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
Obvio Health USA
Languages
English
Recent release
1.1.28 (1 year ago )
Released on
Feb 14, 2023 (2 years ago )
Last Updated
1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.